# AMPICILLIN AND SULBACTAM
> **ANDA065074** · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2002-03-19
## Drug
- **FDA Application Number:** ANDA065074
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMPICILLIN AND SULBACTAM
- **Generic name:** Ampicillin Sodium
- **Active ingredients:** AMPICILLIN SODIUM; SULBACTAM SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** HIKMA
- **First approval:** 2002-03-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065074)
---
*AI Analytics · CC0 1.0*